Eric M. Przybyszewski

602 total citations
22 papers, 283 citations indexed

About

Eric M. Przybyszewski is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Eric M. Przybyszewski has authored 22 papers receiving a total of 283 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 10 papers in Hepatology and 5 papers in Surgery. Recurrent topics in Eric M. Przybyszewski's work include Liver Disease Diagnosis and Treatment (10 papers), Liver Disease and Transplantation (5 papers) and Organ Transplantation Techniques and Outcomes (4 papers). Eric M. Przybyszewski is often cited by papers focused on Liver Disease Diagnosis and Treatment (10 papers), Liver Disease and Transplantation (5 papers) and Organ Transplantation Techniques and Outcomes (4 papers). Eric M. Przybyszewski collaborates with scholars based in United States, India and South Korea. Eric M. Przybyszewski's co-authors include Jere D. Haas, Padmini Ghugre, Shobha Udipi, Sarah Luna, Michael J. Wenger, Kathleen E. Corey, Laura E. Murray‐Kolb, Saurabh Mehta, Julia L. Finkelstein and Giovanni Targher and has published in prestigious journals such as Hepatology, Annals of Surgery and The FASEB Journal.

In The Last Decade

Eric M. Przybyszewski

19 papers receiving 278 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric M. Przybyszewski United States 9 74 73 72 72 71 22 283
Marcos Mucenic Brazil 8 114 1.5× 81 1.1× 114 1.6× 82 1.1× 32 0.5× 15 297
Catherine Rongey United States 10 141 1.9× 30 0.4× 144 2.0× 27 0.4× 72 1.0× 17 321
Sachi Sakaguchi Japan 11 13 0.2× 30 0.4× 40 0.6× 12 0.2× 90 1.3× 24 365
Mauro Liggi Italy 10 13 0.2× 100 1.4× 34 0.5× 81 1.1× 18 0.3× 17 315
Robert Mitchell-Thain United Kingdom 4 201 2.7× 81 1.1× 257 3.6× 15 0.2× 11 0.2× 8 392
Charlotte Stall United States 7 37 0.5× 113 1.5× 39 0.5× 213 3.0× 20 0.3× 10 477
Orazio Sorbello Italy 13 140 1.9× 13 0.2× 156 2.2× 162 2.3× 42 0.6× 23 382
Draško Pavlović Croatia 9 17 0.2× 35 0.5× 26 0.4× 30 0.4× 19 0.3× 47 206
Dominique Criblez Switzerland 7 38 0.5× 119 1.6× 88 1.2× 34 0.5× 16 0.2× 19 355
Markus Dines Knudsen Norway 10 10 0.1× 49 0.7× 52 0.7× 31 0.4× 17 0.2× 29 352

Countries citing papers authored by Eric M. Przybyszewski

Since Specialization
Citations

This map shows the geographic impact of Eric M. Przybyszewski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric M. Przybyszewski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric M. Przybyszewski more than expected).

Fields of papers citing papers by Eric M. Przybyszewski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric M. Przybyszewski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric M. Przybyszewski. The network helps show where Eric M. Przybyszewski may publish in the future.

Co-authorship network of co-authors of Eric M. Przybyszewski

This figure shows the co-authorship network connecting the top 25 collaborators of Eric M. Przybyszewski. A scholar is included among the top collaborators of Eric M. Przybyszewski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric M. Przybyszewski. Eric M. Przybyszewski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Przybyszewski, Eric M. & Camille N. Kotton. (2025). Detection Is Protection: Adherence to Mandated HCV Testing After Liver Transplant. Transplantation. 109(12). 1818–1819. 1 indexed citations
3.
Choi, Jonggi, Tushar Kamath, Vy H. Nguyen, et al.. (2025). GLP1RA and Liver Fibrosis Progression in MASLD and Type 2 Diabetes: Target Trial Emulation Using Propensity Score Matching. Liver International. 45(12). e70447–e70447.
4.
Choi, Jonggi, Vy H. Nguyen, Eric M. Przybyszewski, et al.. (2025). Statin Use and Risk of Hepatocellular Carcinoma and Liver Fibrosis in Chronic Liver Disease. JAMA Internal Medicine. 185(5). 522–522. 9 indexed citations
5.
Sherman, Marc S., Eric M. Przybyszewski, Robert M. Wilechansky, et al.. (2024). A natural language processing algorithm accurately classifies steatotic liver disease pathology to estimate the risk of cirrhosis. Hepatology Communications. 8(4). 2 indexed citations
6.
Przybyszewski, Eric M., Robert M. Wilechansky, Andrew S. Allegretti, et al.. (2024). Controversies in terlipressin and transplantation in the United States: How do we MELD the two?. Liver Transplantation. 30(7). 753–759. 1 indexed citations
7.
Przybyszewski, Eric M. & Raymond T. Chung. (2023). Unmet Needs in the Post–Direct-Acting Antiviral Era: Hepatocarcinogenesis After Hepatitis C Virus Eradication. The Journal of Infectious Diseases. 228(Supplement_3). S226–S231. 1 indexed citations
8.
Shay, Jessica E.S., Augustin Vannier, Stephanie Tsai, et al.. (2023). Moderate-high intensity exercise associates with reduced incident alcohol-associated liver disease in high-risk patients. Alcohol and Alcoholism. 58(5). 472–477. 3 indexed citations
9.
Vannier, Augustin, Amit D. Joshi, Eric M. Przybyszewski, et al.. (2023). Serum Fibroblast Growth Factor-21 Discriminates Between Decompensated Alcohol-Associated Cirrhosis and Severe Alcohol-Associated Hepatitis. Clinical and Translational Gastroenterology. 14(6). e00585–e00585. 3 indexed citations
10.
Bloom, Patricia P., Timothy Gilbert, Eric M. Przybyszewski, et al.. (2023). The incidence and natural history of ascites after liver transplantation. Hepatology Communications. 7(6). 3 indexed citations
11.
Vannier, Augustin, Eric M. Przybyszewski, Jessica E.S. Shay, et al.. (2022). Psychotherapy for Alcohol Use Disorder Is Associated With Reduced Risk of Incident Alcohol-Associated Liver Disease. Clinical Gastroenterology and Hepatology. 21(6). 1571–1580.e7. 21 indexed citations
12.
Luna, Sarah, et al.. (2021). Iron-biofortified pearl millet consumption increases physical activity in Indian adolescent schoolchildren after a 6-month randomised feeding trial. British Journal Of Nutrition. 127(7). 1018–1025. 8 indexed citations
13.
Przybyszewski, Eric M., Giovanni Targher, Michael Roden, & Kathleen E. Corey. (2021). Nonalcoholic Fatty Liver Disease and Cardiovascular Disease. Clinical Liver Disease. 17(1). 19–22. 41 indexed citations
14.
Scheid, Johannes F., Matthew W. Rosenbaum, Eric M. Przybyszewski, et al.. (2021). Next‐generation sequencing in the evaluation of biliary strictures in patients with primary sclerosing cholangitis. Cancer Cytopathology. 130(3). 215–230. 12 indexed citations
15.
Przybyszewski, Eric M., Elizabeth C. Verna, Steven Lobritto, et al.. (2018). Durable Clinical and Immunologic Advantage of Living Donor Liver Transplantation in Children. Transplantation. 102(6). 953–960. 15 indexed citations
16.
Halazun, Karim J., Eric M. Przybyszewski, Adam Griesemer, et al.. (2016). Leaning to the Left. Annals of Surgery. 264(3). 448–456. 38 indexed citations
17.
Finkelstein, Julia L., Saurabh Mehta, Shobha Udipi, et al.. (2015). A Randomized Trial of Iron-Biofortified Pearl Millet in School Children in India ,. Journal of Nutrition. 145(7). 1576–1581. 103 indexed citations
19.
Przybyszewski, Eric M., et al.. (2013). VO 2 max improves in Indian school children after a feeding trail with iron biofortified pearl millet. The FASEB Journal. 27(S1). 2 indexed citations
20.
Rhee, John Y., Michael Lovenheim, Michael J. Wenger, et al.. (2012). Effect of Iron Deficiency on Worker Productivity through Production Function Intermediates. The FASEB Journal. 26(S1). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026